Galderma Brasil Ltda. clinical trials
A country office of Galderma Group AG
The registry lists 6 studies whose lead sponsor is Galderma Brasil Ltda.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 30, 2023.
Registry sponsor names on this page
- Galderma Brasil Ltda.6 studies
Something wrong with this grouping? Tell us on the Galderma Group AG page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Galderma Group AG studies →
- Retrospective Study of the Safety and Efficacy of PLLA for Skin Flaccidity in Labia Majora and/or Pubis RegionRecruitingNCT05940038
Sponsor listed in the registry: Galderma Brasil Ltda.
- Efficacy and Safety of Poly-L-lactic AcidCompletedNCT03225066Not applicable
Sponsor listed in the registry: Galderma Brasil Ltda.
- A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of PhotoagingCompletedNCT01406080Phase 3
Sponsor listed in the registry: Galderma Brasil Ltda.
- A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema.CompletedNCT02856919Phase 4
Sponsor listed in the registry: Galderma Brasil Ltda.
- Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne VulgarisCompletedNCT01149330Phase 4
Sponsor listed in the registry: Galderma Brasil Ltda.
- Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids ApplicationCompletedNCT01063218Phase 4
Sponsor listed in the registry: Galderma Brasil Ltda.